Back to HBIO
RENAISSANCE TECHNOLOGIES LLC → HBIO
RENAISSANCE TECHNOLOGIES LLC HBIO Position History
Harvard Bioscience, Inc. • Healthcare
Quarters held
17
Latest value
$611K
Q2 2026
Peak value
$4.1M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $3.6M |
| Q3 2022 | $2.2M |
| Q4 2022 | $2M |
| Q1 2023 | $3.1M |
| Q2 2023 | $4.1M |
| Q3 2023 | $3.2M |
| Q4 2023 | $3.9M |
| Q1 2024 | $3M |
| Q2 2024 | $2.1M |
| Q3 2024 | $1.9M |
| Q4 2024 | $1.5M |
| Q1 2025 | $500K |
| Q2 2025 | $351K |
| Q3 2025 | $381K |
| Q4 2025 | $683K |
| Q1 2026 | $494K |
| Q2 2026 | $611K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $611K | 99.3K | — | — |
| Q1 2026 | $494K | 101.4K | — | — |
| Q4 2025 | $683K | 1.02M | — | — |
| Q3 2025 | $381K | 868.5K | — | — |
| Q2 2025 | $351K | 792.0K | — | — |
| Q1 2025 | $500K | 883.7K | — | — |
| Q4 2024 | $1.5M | 709.8K | — | — |
| Q3 2024 | $1.9M | 724.1K | — | — |
| Q2 2024 | $2.1M | 745.3K | — | — |
| Q1 2024 | $3M | 702.5K | — | — |
| Q4 2023 | $3.9M | 720.4K | — | — |
| Q3 2023 | $3.2M | 744.7K | — | — |
| Q2 2023 | $4.1M | 752.2K | — | — |
| Q1 2023 | $3.1M | 730.0K | — | — |
| Q4 2022 | $2M | 734.3K | — | — |
| Q3 2022 | $2.2M | 851.5K | — | — |
| Q2 2022 | $3.6M | 1.00M | — | — |